ストックスクリーナーアプリを入手
0.6501
21.74%
0.1161
前日終値:
$0.534
開ける：
$0.719
24時間の取引高:
18,786
Relative Volume:
17.87
時価総額：
$N/A
収益：
-
当期純損益:
$-16.63M
株価収益率:
-1.5119
EPS:
-0.43
ネットキャッシュフロー:
$-21.84M
1週間 パフォーマンス:
+21.74%
1か月 パフォーマンス:
-43.90%
6か月 パフォーマンス:
-68.49%
1年 パフォーマンス:
-87.10%
1日の値動き範囲:
$0.6501
$0.719
1週間の範囲:
$0.6501
$0.719
52週間の値動き範囲:
$0.534
$0.719
Brainstorm Cell Therapeutics Inc Stock (BCLI) Company Profile
Compare BCLI vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCLI
Brainstorm Cell Therapeutics Inc
|
0.6501 | 0 | 0 | -16.63M | -21.84M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-02-04 | アップグレード | Maxim Group | Hold → Buy |
| 2020-11-17 | ダウングレード | Maxim Group | Buy → Hold |
| 2016-12-19 | 繰り返されました | Maxim Group | Buy |
| 2015-12-22 | 繰り返されました | Maxim Group | Buy |
Brainstorm Cell Therapeutics Inc (BCLI) 最新ニュース
BCLI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Brainstorm Cell Therapeutics Adds Shares to Equity Incentive Plan - TipRanks
Brainstorm Cell Therapeutics Arranges Up to $1.0 Million Private Placement at $0.60, Adds Warrants - TradingView
Brainstorm Cell (BCLI) launches $1M private placement and adds 5.5M incentive shares - Stock Titan
BrainStorm Cell Therapeutics to Provide Update on NurOwn Program - GuruFocus
Brainstorm Cell secures second $1M private placement this month By Investing.com - Investing.com Nigeria
Brainstorm Cell secures second $1M private placement this month - Investing.com
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February - PR Newswire
Aug Outlook: Whats the profit margin of Brainstorm Cell Therapeutics IncPortfolio Update Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn
BCLI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Brainstorm Cell Therapeutics Inc. announced that it expects to receive $1 million in funding - marketscreener.com
Brainstorm Cell secures $1M strategic financing - MSN
Brainstorm Cell raises $1M in private placement at premium pricing - Investing.com Nigeria
Loss Report: Is Brainstorm Cell Therapeutics Inc stock undervalued right now2025 Short Interest & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Published on: 2026-02-20 18:26:53 - mfd.ru
Brainstorm Cell Therapeutics announces $1 million strategic financing at premium to market - marketscreener.com
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market - TradingView
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market - Financial Times
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - The Manila Times
Setup Watch: What is the target price for Brainstorm Cell Therapeutics Inc stockTrade Volume Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn
Market Outlook: Is Brainstorm Cell Therapeutics Inc. stock risky to hold nowJuly 2025 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Tech Rally: Can Brainstorm Cell Therapeutics Inc be the next market leaderJuly 2025 Volume & Capital Protection Trade Alerts - baoquankhu1.vn
Brainstorm Cell Therapeutics Announces New Private Placement Financing - The Globe and Mail
What is the target price for Brainstorm Cell Therapeutics Inc. stockJuly 2025 Update & Fast Gain Swing Trade Alerts - mfd.ru
Brainstorm Cell Therapeutics Signs Securities Purchase Agreement With Accredited Investor - TradingView
Is Brainstorm Cell Therapeutics Inc. in a long term uptrend2025 Investor Takeaways & Expert Curated Trade Setup Alerts - mfd.ru
What’s the profit margin of Brainstorm Cell Therapeutics Inc.Trade Entry Report & Community Consensus Stock Picks - mfd.ru
BrainStorm Cell Therapeutics Submits Type A Meeting Request to U.S. Food and Drug Administration - Nasdaq
Biotech Stocks To Keep An Eye On – January 22nd - Defense World
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Hits New 52-Week HighHere's What Happened - MarketBeat
Biotech Stocks To Keep An Eye OnJanuary 22nd - MarketBeat
Weekly Earnings: Is Brainstorm Cell Therapeutics Inc in a long term uptrend2025 Price Momentum & Real-Time Volume Analysis - baoquankhu1.vn
Amyotrophic Lateral Sclerosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharma - The Globe and Mail
What Wall Street predicts for Brainstorm Cell Therapeutics Inc. stock priceJuly 2025 Snapshot & Fast Exit and Entry Trade Guides - Улправда
Brainstorm Cell Therapeutics Secures New Convertible Debt Financing - TipRanks
Brainstorm Cell Therapeutics Signs Multiple Financing Agreements - TradingView — Track All Markets
Brainstorm Cell Therapeutics (BCLI) raises cash via new unsecured convertible notes - Stock Titan
Why retail investors favor Brainstorm Cell Therapeutics Inc. stockWeekly Trend Summary & Long-Term Growth Plans - Улправда
Is Brainstorm Cell Therapeutics Inc. stock dividend yield sustainableMarket Trend Report & Growth Focused Entry Point Reports - ulpravda.ru
Is Brainstorm Cell Therapeutics Inc. (GHD) stock among top earnings playsJuly 2025 Price Swings & Risk Controlled Daily Plans - Улправда
Can Brainstorm Cell Therapeutics Inc. (GHD) stock surprise with quarterly resultsJuly 2025 Chart Watch & AI Based Trade Execution Alerts - Улправда
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Share Price Crosses Below 200 Day Moving Average – Here’s What Happened - Defense World
Is Brainstorm Cell Therapeutics Inc GHD a good long term investmentIPO Market Watch & Stay Safe With Built-In Risk Monitoring - earlytimes.in
BrainStorm Shareholder Seeks Access to Board’s FDA Snub Records - Bloomberg Law News
Can Brainstorm Cell Therapeutics Inc. stock outperform in 2025 bull marketMarket Risk Report & Free Daily Entry Point Trade Alerts - Улправда
Why Brainstorm Cell Therapeutics Inc. stock appeals to analysts2025 Winners & Losers & Daily Stock Trend Watchlist - Улправда
Why Brainstorm Cell Therapeutics Inc. stock remains a top recommendationDip Buying & Capital Efficiency Focused Strategies - DonanımHaber
Can Brainstorm Cell Therapeutics Inc. stock deliver consistent earnings growthJuly 2025 Reactions & Weekly Top Stock Performers List - DonanımHaber
How Brainstorm Cell Therapeutics Inc. stock reacts to global recession fearsJuly 2025 Sentiment & Proven Capital Preservation Methods - DonanımHaber
Will Brainstorm Cell Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 Institutional & Real-Time Volume Triggers - Улправда
Maxim Group downgrades Brainstorm Cell Therapeutics (BCLI) - MSN
Brainstorm Cell Therapeutics Inc (BCLI) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
6.00%
大文字化:
|
ボリューム (24 時間):